Masahiro Ota Selected Research

Masahiro Ota Research Topics

Disease

6	Osteoporosis 10/2020 - 02/2016
5	Neoplasms (Cancer) 12/2019 - 10/2003
3	Bone Resorption 01/2020 - 10/2015
2	Juvenile osteoporosis 01/2020 - 11/2018
2	Breast Neoplasms (Breast Cancer) 12/2019 - 11/2019
2	Pulmonary Embolism 02/2005 - 07/2003
1	COVID-19 11/2023
1	Dementia (Dementias) 11/2023
1	Mental Disorders (Mental Disorder) 11/2023
1	Delirium 11/2023
1	Pneumonia (Pneumonitis) 09/2023
1	Ankylosing Spondylitis 06/2022
1	Pain (Aches) 06/2022
1	Thrombocytopenia (Thrombopenia) 11/2021
1	Non-alcoholic Fatty Liver Disease 11/2021
1	Compression Fractures (Compression Fracture) 04/2021
1	Wounds and Injuries (Trauma) 04/2021
1	Hematoma 04/2021
1	Hemorrhage 04/2021
1	Paralysis (Palsy) 04/2021
1	Chronic Renal Insufficiency 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 07/2020
1	Osteonecrosis (Kienbock's Disease) 07/2020
1	Hip Fractures (Intertrochanteric Fractures) 03/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019
1	Postmenopausal Osteoporosis 03/2019
1	Bone Fractures (Bone Fracture) 03/2019
1	Hypocalcemia 03/2019
1	Dehydration (Water Stress) 01/2018
1	Heterotopic Ossification (Ectopic Ossification) 01/2018
1	Osteolysis 01/2018
1	Rheumatoid Arthritis 01/2018
1	Ankylosis 02/2016
1	Diffuse Idiopathic Skeletal Hyperostosis 02/2016
1	Inflammation (Inflammations) 10/2015
1	Arthritis (Polyarthritis) 10/2015
1	Weight Gain 01/2015
1	Transient Ischemic Attack 08/2010
1	Carotid Stenosis (Carotid Artery Stenosis) 08/2010
1	Pathologic Constriction (Stenosis) 08/2010

Drug/Important Bio-Agent (IBA)

4	Diphosphonates (Bisphosphonates)IBA 10/2020 - 11/2018
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 10/2015
3	LectinsIBA 01/2020 - 10/2015
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2020 - 10/2015
3	AntigensIBA 12/2019 - 08/2006
3	Teriparatide (Parathar)FDA Link 03/2019 - 02/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2022 - 01/2018
2	Bone Density Conservation AgentsIBA 07/2020 - 03/2019
2	Neutralizing AntibodiesIBA 01/2020 - 11/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 10/2003
1	Serum AlbuminIBA 11/2023
1	hemoglobin P (Hb P)IBA 11/2023
1	Heparin (Liquaemin)FDA LinkGeneric 04/2021
1	AnticoagulantsIBA 04/2021
1	Warfarin (Coumadin)FDA LinkGeneric 04/2021
1	Therapeutic UsesIBA 10/2020
1	GlucocorticoidsIBA 01/2020
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2020
1	Polysaccharides (Glycans)IBA 12/2019
1	CarbohydratesIBA 12/2019
1	sialosyl-Tn antigenIBA 12/2019
1	IntegrinsIBA 12/2019
1	EpitopesIBA 12/2019
1	SulfonamidesIBA 11/2019
1	Benzoic Acid (Potassium Benzoate)FDA Link 11/2019
1	ErbB Receptors (EGF Receptor)IBA 08/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2019
1	Tyrosine Kinase InhibitorsIBA 08/2019
1	Phosphotransferases (Kinase)IBA 08/2019
1	CarbonIBA 06/2019
1	Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA 06/2019
1	IsoenzymesIBA 06/2019
1	eldecalcitol (ED 71)IBA 03/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 03/2019
1	LigandsIBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2018
1	MineralsIBA 01/2018
1	CarbonatesIBA 01/2018
1	ChemokinesIBA 01/2018
1	Polymethyl Methacrylate (Sol)IBA 01/2018
1	Alkaline PhosphataseIBA 01/2018
1	ultra-high molecular weight polyethylene (UHMWPE)IBA 01/2018
1	Fc Receptors (Fc Receptor)IBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 10/2015
1	AmidesIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	Dexmedetomidine FDA Link 08/2010

Therapy/Procedure

6	Therapeutics 01/2020 - 07/2003
1	Mechanical Ventilators (Ventilator) 09/2023
1	Laminoplasty 11/2021
1	Length of Stay 04/2021
1	Tooth Extraction (Tooth Extractions) 07/2020
1	Drug Therapy (Chemotherapy) 03/2020
1	Postoperative Care 03/2020
1	Oral Administration 11/2019
1	Arthroplasty 01/2018
1	Carotid Endarterectomy 08/2010
1	Anesthesia 08/2010